Search

everythinglearnresearchcommunity

for

Search:↓

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

PRP injections did not significantly improve ovarian function in women with low ovarian reserve.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Estrogens can slow skin aging after menopause, but can't restore youthful skin.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Skin hormone levels change significantly after menopause.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Contraceptives may affect hair growth due to estrogen, with effects varying by individual.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

Hormonal intrauterine devices (IUDs) may cause or worsen skin conditions influenced by androgens.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

A new method was developed to make finasteride for treating hair loss.

Estradiol stops hair growth in mice, but an antagonist can reverse this effect.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

During puberty, hormone levels rise, with early increases in some steroids and most menstrual cycles becoming regular by six years after menarche.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Individualized treatment plans, including lifestyle changes and specific medications, are crucial for managing PCOS in adolescents.

Ovariectomized mice mimic postmenopausal hair loss, and estradiol helps maintain hair density.

Bimatoprost, a glaucoma medication, may also help treat hair loss.